DNA damage response and repair in the development and treatment of brain tumors

被引:9
作者
Dana, Parisa Maleki [1 ]
Sadoughi, Fatemeh [1 ]
Mirzaei, Hamed [1 ]
Asemi, Zatollah [1 ]
Yousefi, Bahman [2 ,3 ]
机构
[1] Kashan Univ Med Sci, Inst Basic Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran
[2] Tabriz Univ Med Sci, Mol Med Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Med, Dept Biochem, Tabriz, Iran
关键词
DNA damage response; Glioma; Glioblastoma; Medulloblastoma; Drug resistance; STRAND BREAK REPAIR; CENTRAL-NERVOUS-SYSTEM; TEMOZOLOMIDE RESISTANCE; GENE POLYMORPHISMS; GLIOBLASTOMA CELLS; CELLULAR-RESPONSE; GLIOMA-CELLS; EXPRESSION; CANCER; ATM;
D O I
10.1016/j.ejphar.2022.174957
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
DNA damage response (DDR) comprising DNA repair and cell-cycle checkpoint pathways, is considered as a protective process that maintains the integrity of the genome. However, this mechanism may not be favorable in the context of cancer. Indeed, studies have shown that DDR and repair mechanisms can be involved in the development of different cancers. Furthermore, they may lead to the failure of therapeutic approaches. Thus, studying these mechanisms can be beneficial in a better understanding of cancer development and developing more efficient treatments. Scopus, Google Scholar, and PubMed databases were used for searching articles published on "DNA damage response and DNA repair in the development and treatment of brain tumors". Herein, we review the literature on DNA damage response and DNA repair mechanisms in the development of brain tumors, such as glioma, glioblastoma, and medulloblastoma. Moreover, we summarize the studies that conducted on the role of targeting components of DNA damage response and DNA repair in treating different types of brain cancers, enhancing the currently available therapeutic approaches, and solving the problems in the field of brain cancer therapy.
引用
收藏
页数:12
相关论文
共 160 条
  • [81] A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese
    Lu, Chao
    Chen, Yi-Dong
    Han, Sichong
    Wei, Jinyu
    Ge, Yunxia
    Pan, Wenting
    Jiang, Tao
    Qiu, Xiao-Guang
    Yang, Ming
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2014, 120 (01) : 11 - 17
  • [82] Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair
    Lu, Yanxin
    Kwintkiewicz, Jakub
    Liu, Yang
    Tech, Katherine
    Frady, Lauren N.
    Su, Yu-Ting
    Bautista, Wendy
    Moon, Seog In
    MacDonald, Jeffrey
    Ewend, Matthew G.
    Gilbert, Mark R.
    Yang, Chunzhang
    Wu, Jing
    [J]. CANCER RESEARCH, 2017, 77 (07) : 1709 - 1718
  • [83] Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining
    Mahaney, Brandi L.
    Meek, Katheryn
    Lees-Miller, Susan P.
    [J]. BIOCHEMICAL JOURNAL, 2009, 417 : 639 - 650
  • [84] Repurposing of mTOR Complex Inhibitors Attenuates MCL-1 and Sensitizes to PARP Inhibition
    Mattoo, Abid R.
    Joun, Alex
    Jessup, J. Milburn
    [J]. MOLECULAR CANCER RESEARCH, 2019, 17 (01) : 42 - 53
  • [85] Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours
    McCrorie, Phoebe
    Mistry, Jatin
    Taresco, Vincenzo
    Lovato, Tatiana
    Fay, Michael
    Ward, Ian
    Ritchie, Alison A.
    Clarke, Philip A.
    Smith, Stuart J.
    Marlow, Maria
    Rahman, Ruman
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 157 : 108 - 120
  • [86] Associations between Polymorphisms in DNA Repair Genes and Glioblastoma
    McKean-Cowdin, Roberta
    Barnholtz-Sloan, Jill
    Inskip, Peter D.
    Ruder, Avima M.
    Butler, MaryAnn
    Rajaraman, Preetha
    Razavi, Pedram
    Patoka, Joe
    Wiencke, John K.
    Bondy, Melissa L.
    Wrensch, Margaret
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (04) : 1118 - 1126
  • [87] The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity
    Mirzoeva, Olga K.
    Kawaguchi, Tomohiro
    Pieper, Russell O.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) : 2757 - 2766
  • [88] PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells
    Motta, Carla
    D'Angeli, Floriana
    Scalia, Marina
    Satriano, Cristina
    Barbagallo, Davide
    Naletova, Irina
    Anfuso, Carmelina Daniela
    Lupo, Gabriella
    Spina-Purrello, Vittoria
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 761 : 55 - 64
  • [89] Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage
    Munoz, Ivan M.
    Jowsey, Paul A.
    Toth, Rachel
    Rouse, John
    [J]. NUCLEIC ACIDS RESEARCH, 2007, 35 (16) : 5312 - 5322
  • [90] PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
    Murnyak, Balazs
    Kouhsari, Mahan C.
    Hershkovitch, Rotem
    Kalman, Bernadette
    Marko-Varga, Gyorgy
    Klekner, Almos
    Hortobagyi, Tibor
    [J]. ONCOTARGET, 2017, 8 (28) : 46348 - 46362